SCHEMBL6561715

SCHEMBL6561715

CCCc1c(O)ccc2c(C(C)(C)C)c(C)c(=O)oc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 6/20 0.50
ESR1 P03372 5/20 0.50
KDM4E B2RXH2 6/20 0.47
GAA P10253 6/20 0.47
ALDH1A1 P00352 5/20 0.47
GLA P06280 4/20 0.47
ERAP1 Q9NZ08 3/20 0.47
HPGD P15428 3/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
HSD17B10 Q99714 1/20 0.47
HSD17B3 P37058 1/20 0.44
HIF1A Q16665 2/20 0.40
SHBG P04278 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HTT P42858 1/20 0.40
CSNK2A1 P68400 1/20 0.40
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11220015 0.86 ERAP1 (0.60) ESR2ESR1KDM4EGAAALDH1A1
SCHEMBL11216726 0.80 KDM4E (0.60) ESR2ESR1KDM4EGAAALDH1A1
SCHEMBL6559867 0.78 ESR1 (0.52) ESR2ESR1KDM4EGAAALDH1A1
SCHEMBL6559983 0.76 MAOB (0.43) KDM4EGAAALDH1A1HPGDSMN1; SMN2
SCHEMBL6561597 0.75 ALDH1A1 (0.51) KDM4EGAAALDH1A1GLAERAP1
SCHEMBL10651585 0.73 KDM4E (0.72) KDM4EGAAALDH1A1GLAERAP1
SCHEMBL11079352 0.72 GAA (0.63) KDM4EGAAALDH1A1GLAERAP1
SCHEMBL6561714 0.70 KDM4E (0.58) KDM4EGAAALDH1A1GLAERAP1
SCHEMBL6559997 0.70 GAA (0.71) KDM4EGAAALDH1A1GLAERAP1
SCHEMBL10794043 0.70 HSD17B3 (0.45) ESR2ESR1HSD17B3SHBG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0904079-B1 ANTIDIABETIC AGENTS MERCK & CO INC (US) 2004-03-24 EP disclosed
EP-0904079-A4 1999-05-06 EP disclosed
EP-0904079-A1 ANTIDIABETIC AGENTS Merck & Co., Inc. (US) 1999-03-31 EP disclosed
US-5859051-A ACETYLPHENOL DERIVATIVES MERCK & CO., INC. (US) 1999-01-12 US disclosed
WO-1997027857-A1 ANTIDIABETIC AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed